Get Started
HBV Curricula
Step 1
Curriculum VII
Curriculum VI
Curriculum V
Curriculum IV
These independent CME/CE activities are supported by educational grants from Bristol-Myers Squibb

Gilead Sciences, Inc.




Chronic Hepatitis B:
The Advanced Curriculum
  1. Curriculum VII
  2. Curriculum VI
  3. Curriculum V
  4. Curriculum IV
  5. Full Course List
Search by


Currently Available

Course Title Curriculum Faculty Release Date
Video Case Study 4: Guidance and Insights for Managing Your Patients with HBV Treating HBV Patients with Renal InsufficiencyVideo Case Vignette (HBV7.10) 2101.04 VII Kowdley Dec 2012
Case Study: Treatment-Experienced Patient on Long-Term Suboptimal Therapy: Why and How to SwitchTx Reporter e-Newsletter (HBV7.09) 2100.02 VII Di Bisceglie Dec 2012
Expert Insight Into: Combination Nucleos(t)ide Analog Therapy vs Nucleos(t)ide Analog Monotherapy in Patients with Chronic Hepatitis B (Part 3 of Series)Article Review (HBV7.08) 2099.03 VII Te Nov 2012
Video Case Study 3: Guidance and Insights for Managing Your Patients with HBV - Acute Hepatitis B InfectionVideo Case Vignette (HBV7.07) 2101.03 VII Te Sep 2012
Future Directions in HCC Prevention and TreatmentWebcast (HBV7.06) 2102 VII Gish
El-Serag
Min
Sep 2012
Video Case Study 2: Guidance and Insights for Managing Your Patients with HBV -Who to Treat and Who Not to TreatVideo Case Vignette (HBV7.05) 2101.02 VII Di Bisceglie Aug 2012
Expert Insight Into: Polymorphisms Near IL28B and Serologic Response to Peginterferon in HBeAg-Positive Patients with Chronic Hepatitis B (Part 2 of Series)Article Review (HBV7.04) 2099.02 VII Di Bisceglie Jul 2012
Case Study: East African Patient with HBV Infection and a High Risk of HCCTx Reporter e-Newsletter (HBV7.03) 2100.01 VII Gish
Kowdley
Jun 2012
Video Case Study 1: Guidance and Insights for Managing Your Patients with HBV - Global HBV TestingVideo Case Vignette (HBV7.02) 2101.01 VII Gish May 2012
Expert Insight Into: Prevalence of Chronic Hepatitis B Among Foreign-Born Persons Living in the United States by Country of Origin (Part 1 of Series)Article Review (HBV7.01) 2099.01 VII Kowdley Apr 2012
Expert Insight Into: Peginterferon Plus a Nucleotide Analog Versus Either Drug Alone for Hepatitis Delta (Part 6 of Series)Article Review (HBV6.18) 2029.06 VI Nguyen Dec 2011
Case Study: Managing HBV Infection Following Liver TransplantTx Reporter e-Newsletter (HBV6.17) 2030.04 VI Nguyen Dec 2011
Long-Term Anti-HBV Therapy Considerations Podcast Series (HBV6.16) 2031.02 VI Di Bisceglie
Tran
Dec 2011
Video Case Study 6: Practical Guidance and Insights for Managing Your Patients with HBV - Non-English-Speaking Asymptomatic PatientVideo Case Vignette (HBV6.15) 2032.06 VI Di Bisceglie Nov 2011
Case Study: HBV Reactivation in the Immunocompromised Rheumatology PatientTx Reporter e-Newsletter (HBV6.14) 2030.03 VI Di Bisceglie
Rustgi
Oct 2011
Expert Insight Into: Nucleos(t)ide Analog Therapy in Patients with Decompensated Chronic Hepatitis B Liver Disease (Part 5 of Series)Article Review (HBV6.13) 2029.05 VI Te Oct 2011
Video Case Study 5: Practical Guidance and Insights for Managing Your Patients with HBV - Partial ResponderVideo Case Vignette (HBV6.12) 2032.05 VI Te Oct 2011
Video Case Study 4: Practical Guidance and Insights for Managing Your Patients with HBV - Hepatocellular CarcinomaVideo Case Vignette (HBV6.11) 2032.04 VI Gish Oct 2011
Expert Insight Into: Hepatitis B Virus in the United States: Infection, Exposure, and Immunity Rates in a Nationally Representative Survey (Part 4 of Series)Article Review (HBV6.10) 2029.04 VI Tran Sep 2011
Case Study: Important Factors for Treatment Decisions in HBV-Infected PatientsTx Reporter e-Newsletter (HBV6.09) 2030.02 VI Tran Sep 2011
Video Case Study 3: Practical Guidance and Insights for Managing Your Patients with HBV - Screening by PCPsVideo Case Vignette (HBV6.08) 2032.03 VI Nguyen Aug 2011
Video Case Study 2: Practical Guidance and Insights for Managing Your Patients with HBV - Linkage to CareVideo Case Vignette (HBV6.07) 2032.02 VI Tran Jul 2011
A Model for Involving the Community in Hepatitis HealthcarePodcast Series (HBV6.06) 2031.01 VI Gish
Fang
Jun 2011
Video Case Study 1: Practical Guidance and Insights for Managing Your Patients with HBV - Vaccine NonresponseVideo Case Vignette (HBV6.05) 2032.01 VI Rustgi Jun 2011
Expert Insight Into: Virological Breakthrough and Resistance in Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in Clinical Practice (Part 3 of Series)Article Review (HBV6.04) 2029.03 VI Rustgi Jun 2011
Case Study: Testing and Interpretation of Hepatitis B Serologic Markers and Other Markers of Disease ActivityTx Reporter e-Newsletter (HBV6.03) 2030.01 VI Te May 2011
Expert Insight Into: Grabbing the Rice Straw: Health Information Seeking in Chinese Immigrants in the United States (Part 2 of Series)Article Review (HBV6.02) 2029.02 VI Gish Apr 2011
Expert Insight Into: Hepatitis B Virus Infection Among Refugees Resettled in the U.S.: High Prevalence and Challenges in Access to Health Care (Part 1 of Series)Article Review (HBV6.01) 2029.01 VI Di Bisceglie Apr 2011
Expert Insight Into: A Nucleotide Analog Is Effective Alone or with a Nucleoside Analog in Chronic Hepatitis B Patients Previously Treated with Another Nucleotide Analog (Part 12 of Series)Article Review (HBV5.17) 1969.12 V Kim Dec 2010
Case Study: Focus on Long-Term TherapyTx Reporter e-Newsletter (HBV5.15) 1967.04 V Gish
Nguyen
Dec 2010
Expert Insight Into: Possible Reactivation of Potential Hepatitis B Virus Occult Infection by Tumor Necrosis Factor-alpha Blocker in the Treatment of Rheumatic Diseases (Part 11 of Series)Article Review (HBV5.16) 1969.11 V Pan Nov 2010
Expert Insight Into: Long-Term Efficacy of a Nucleotide Analog for Hepatitis B Virus-Monoinfected Patients After Failure of Other Nucleos(t)ide Analogs (Part 10 of Series)Article Review (HBV5.14) 1969.10 V Nguyen Nov 2010
Profiles in Hepatitis B: Customized, Interactive Case ScenariosWebcast w/ Branched Learning (HBV5.12) 1968 V Gish
Kim
Tran
Sep 2010
Expert Insight Into: Nucleoside Analog Treatment for Up to 5 Years in Patients with Hepatitis B e Antigen-positive Chronic Hepatitis B (Part 9 of Series)Article Review (HBV5.13) 1969.09 V Gish Sep 2010
Expert Insight Into: Severe Lactic Acidosis During Treatment of Chronic Hepatitis B with a Nucleoside Analog in Patients with Impaired Liver Function (Part 8 of Series)Article Review (HBV5.11) 1969.08 V Tran Aug 2010
Case Study: Focus on ReactivationTx Reporter e-Newsletter (HBV5.10) 1967.03 V Di Bisceglie Jul 2010
Expert Insight Into: Efficacy of Antiviral Therapy in Chronic Hepatitis B Patients with Mildly Elevated ALT and Histological Liver Damage (Part 7 of Series)Article Review (HBV5.09) 1969.07 V Di Bisceglie Jul 2010
Expert Insight Into: Perinatal Transmission of Hepatitis B Virus: An Australian Experience (Part 6 of Series)Article Review (HBV5.08) 1969.06 V Pan Jun 2010
Expert Insight Into: Incidence and Risk Factors of Progression to Cirrhosis in Inactive Carriers of Hepatitis B Virus (Part 5 of Series)Article Review (HBV5.07) 1969.05 V Nguyen May 2010
Case Study: Focus on Basic Disease Management (the "Grey Zone" Patient)Tx Reporter e-Newsletter (HBV5.06) 1967.02 V Gish
Tran
May 2010
Expert Insight Into: Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-Up Study (Part 4 of Series)Article Review (HBV5.05) 1969.04 V Di Bisceglie Apr 2010
Expert Insight Into: Prevalence of Hepatitis B Surface Antigen Among Refugees Entering the United States Between 2006 and 2008 (Part 3 of Series)Article Review (HBV5.04) 1969.03 V Tran Apr 2010
Expert Insight Into: Hepatitis B Testing and Vaccination Among Vietnamese- and Cambodian-Americans (Part 2 of Series)Article Review (HBV5.03) 1969.02 V Gish Mar 2010
Case Study: Focus on Screening and TestingTx Reporter e-Newsletter (HBV5.02) 1967.01 V Di Bisceglie
Pan
Mar 2010
Expert Insight Into: Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C (Part 1 of Series)Article Review (HBV5.01) 1969.01 V Kim Feb 2010
Expert Insight Into: Current Best Practices in Hepatitis B Treatment: Optimizing Response while Avoiding ResistanceArticle Review (HBV4.18) 1880.13 IV Di Bisceglie Dec 2009
Expert Insight Into: Clinical Outcomes of HBV Superinfection in Chronic Carriers of HCVArticle Review (HBV4.17) 1880.12 IV Kim Nov 2009
Expert Insight Into: Liver Fibrosis: Consensus Recommendations of the Asian Pacific Association for the Study of the Liver (APASL) Article Review (HBV4.16) 1880.11 IV Kim Nov 2009
Expert Insight Into: Renal Dysfunction in Asian American Patients with Chronic Hepatitis B Treated with an Oral Nucleotide AnalogueArticle Review (HBV4.15) 1880.10 IV Han Oct 2009
Case Study: HBsAg-Positive, Anti-HBe-Negative Black Immigrant from SomaliaTx Reporter e-Newsletter (HBV4.14) 1881.04 IV Di Bisceglie
Kim
Oct 2009
Expert Insight Into: Early Serum HBsAg Drop: A Strong Predictor of Sustained Virological Response in HBeAg-Negative PatientsArticle Review (HBV4.13) 1880.09 IV Tsai Aug 2009
Expert Insight Into: Treatment of Chronic Hepatitis Delta Virus (HDV) Infection with Single Therapies vs Combination TherapyArticle Review (HBV4.12) 1880.08 IV Gish Jul 2009
Case Study: HBeAg-Negative Turkish PatientTx Reporter e-Newsletter (HBV4.11) 1881.03 IV Gish
Han
Jul 2009
Expert Insight Into: Long-Term Chronic HBV Therapy with Investigational Nucleoside Associated with Myopathy

Based on the article:
Long-Term Therapy with Clevudine for Chronic Hepatitis B Can Be Associated with Myopathy Characterized by Depletion of Mitochondrial DNA
Article Review (HBV4.10) 1880.07
IV Han Jun 2009
Expert Insight Into: Is There a Meaningful Serum HBV DNA Cutoff Level for Therapeutic Decisions in HBeAg-Negative Chronic HBV Infection?Article Review (HBV4.09) 1880.06 IV Tsai May 2009
Case Study: Chinese-Born HBeAg-Positive Pregnant PatientTx Reporter e-Newsletter (HBV4.08) 1881.02 IV Di Bisceglie
Han
May 2009
Expert Insight Into: Comparison of Two Approved Nucleotide Analogs for Chronic Hepatitis BArticle Review (HBV4.07) 1880.05 IV Gish Apr 2009
New HBV Screening Guidelines from the CDC: Emphasis on Immigrants from Endemic Areas and Others at Risk for HBVAudio Interview (HBV4.06) 1882 IV Di Bisceglie
Tsai
Ward
Apr 2009
Expert Insight Into: Treatment Recommendations for Chronic Hepatitis B: An Evaluation of Current Guidelines Based on a Natural History Study in the United StatesArticle Review (HBV4.05) 1880.04 IV Kim Apr 2009
Case Study: HBeAg-Positive Vietnamese PatientTx Reporter e-Newsletter (HBV4.04) 1881.01 IV Gish
Tsai
Mar 2009
Expert Insight Into: Systematic Review: The Effect of Preventive Nucleoside Analog Therapy on Hepatitis B Reactivation During ChemotherapyArticle Review (HBV4.03) 1880.03 IV Di Bisceglie Feb 2009
Expert Insight Into: Recommendations for Identification and Public Health Management of Persons with Chronic Hepatitis B Virus InfectionArticle Review (HBV4.02) 1880.02 IV Kim Jan 2009
Expert Insight Into: Seroepidemiology of Hepatitis B Virus Infection: Analysis of Mass Screening in HawaiiArticle Review (HBV4.01) 1880.01 IV Han Jan 2009